|
gptkbp:instanceOf
|
gptkb:drug
alkaloid
|
|
gptkbp:approvedBy
|
1962
|
|
gptkbp:ATCCode
|
G02AB01
|
|
gptkbp:CASNumber
|
511-12-6
|
|
gptkbp:contraindication
|
hypertension
ischemic heart disease
pre-eclampsia
|
|
gptkbp:discoveredBy
|
gptkb:Sandoz
|
|
gptkbp:eliminationHalfLife
|
0.5–2 hours
|
|
gptkbp:excretion
|
urine
bile
|
|
gptkbp:hasMolecularFormula
|
C20H25N3O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
methylergometrine
|
|
gptkbp:KEGGID
|
D08144
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
induces uterine contractions
|
|
gptkbp:MedlinePlusID
|
a682330
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:otherName
|
methylergometrine maleate
methylergonovine
|
|
gptkbp:partOf
|
gptkb:WHO_Model_List_of_Essential_Medicines
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
CHEMBL1201207
5281060
DB00353
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nausea
vomiting
headache
hypertension
|
|
gptkbp:UNII
|
8Y164V895Y
|
|
gptkbp:usedFor
|
prevention of postpartum hemorrhage
treatment of postpartum hemorrhage
|
|
gptkbp:bfsParent
|
gptkb:lysergic_acid
gptkb:Lysergic_acid
|
|
gptkbp:bfsLayer
|
7
|